✦ LIBER ✦

Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal

✍ Scribed by Sung-Hee Cho; Man Ho Choi; Won-Yong Lee; Bong Chul Chung

Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 274 KB
Volume: 42
Category: Article
ISSN: 0009-9120
DOI: 10.1016/j.clinbiochem.2008.12.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance and prognostic val

Clinical significance and prognostic value of urinary nucleosides in breast cancer patients

✍ Yu-Fang Zheng; Hong-Wei Kong; Jian-Hui Xiong; Shen Lv; Guo-Wang Xu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Expression of sIL-2R before and after ch

Expression of sIL-2R before and after chemotherapy in patients with breast cancer

✍ Yuan-ming Fan; Zhi-jun Sun 📂 Article 📅 2008 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 320 KB

Bilateral ovariectomy in premenopausal p

Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion

✍ Saro Oriana; Giorgio Secreto; Aldo Severini; Giovanni Di Fronzo; Maria Di Giusep 📂 Article 📅 1982 🏛 Springer US 🌐 English ⚖ 351 KB

Psychological evaluation of patients aft

Psychological evaluation of patients after breast cancer surgery and care strategies improvement

✍ Yanjun Zhang; Caigang Liu; Feng Jin 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 234 KB

Evaluation of serum tumor markers in pat

Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer

✍ Hirotaka Iwase; Shunzo Kobayashi; Yukashi Itoh; Hideki Fukuoka; Tatsuya Kuzushim 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 431 KB

MRI evaluation of pathologically complet

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy

✍ Jeon Hor Chen; Byon Feig; Garima Agrawal; Hon Yu; Philip M. Carpenter; Rita S. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

## Abstract ## BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in evaluation of pathologically complete response and residual tumors in patients who were receiving neoadjuvant chemotherapy (NAC) for both positive and negative HER‐2 breast cancer. ## METHODS. Fift